Amgen Files Definitive Proxy Materials
Ticker: AMGN · Form: DEFA14A · Filed: Apr 17, 2025 · CIK: 318154
| Field | Detail |
|---|---|
| Company | Amgen INC (AMGN) |
| Form Type | DEFA14A |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting
Related Tickers: AMGN
TL;DR
Amgen filed its proxy statement, shareholders vote soon.
AI Summary
Amgen Inc. filed a Definitive Additional Materials proxy statement on April 17, 2025. This filing is related to the company's annual meeting and is not a preliminary proxy statement. No fee was required for this filing.
Why It Matters
This filing provides important information to shareholders regarding the company's annual meeting, including voting matters and executive compensation details.
Risk Assessment
Risk Level: low — This is a routine filing of proxy materials for an annual meeting, not indicating any unusual risks.
Key Players & Entities
- AMGEN INC. (company) — Registrant
- 0000950170-25-055585 (filing_id) — Accession Number
- 20250417 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically 'Definitive Additional Materials' filed by Amgen Inc.
When was this filing made?
The filing was made on April 17, 2025.
Who is the registrant for this filing?
The registrant is Amgen Inc.
Is this a preliminary proxy statement?
No, this is marked as 'Definitive Additional Materials' and not a 'Preliminary Proxy Statement'.
Was there a fee associated with this filing?
No, the filing indicates 'No fee required'.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 17, 2025 regarding AMGEN INC (AMGN).